
Frederick G L Huetwell Collegiate Professor of Cardiovascular Medicine and Professor of Internal Medicine
Medical School
Internal Medicine/Division of Cardiovascular Medicine
1500 E. Medical Center Dr., Frankel Cardiovascular Center, #2722G
Ann Arbor, MI 48109
[email protected]
1500 E. Medical Center Dr., Frankel Cardiovascular Center, #2722G
Ann Arbor, MI 48109
Available to mentor
Kenneth A Jamerson

Professor
-
Sabbatical LeaveCardiovascular Research Institute, Morehouse School of Medicine, Atlanta, 2008
-
FellowAmerican Heart Association Summer Course on Cardiovascular Epidemiology, United States, 1993
-
FellowUniversity of Michigan Medical School, Internal Medicine, Division of Hypertension, 1990
-
House OfficerUniversity of Michigan Medical School, Internal Medicine, 1989
-
BSUniversity of Michigan–Ann Arbor, 1982
-
Center MemberSamuel and Jean Frankel Cardiovascular Center
Dr. Jamerson’s basic research addresses the role of sympathetic tone on the metabolism of glucose in human skeletal muscle. Current clinical research focuses on hypertensive nephropathy; non-invasive hemodynamic assessment of organ function and damage in the natural history of hypertension; and insulin resistance in hypertension.
-
Olsen E, Jamerson K, Schmieder RE, Søraas CL, Mariampillai JE, Mancia G, Kjeldsen SE, Heimark S, Mehlum MH, Liestøl K, Larstorp ACK, Halvorsen LV, Høieggen A, Burnier M, Rostrup M, Julius S, Weber MA. European Journal of Internal Medicine, 2025 Mar 1; 133: 55 - 63.Journal ArticleEffects of valsartan vs amlodipine and achieved lower blood pressure on the incidence of end-stage kidney disease: The VALUE Trial
DOI:10.1016/j.ejim.2024.12.021 PMID: 39694747 -
2024 Oct 7;PresentationResistant Hypertension
-
Ku E, Jamerson K, Copeland TP, McCulloch CE, Tighiouart H, Sarnak MJ. Journal of the American Heart Association, 2024 Aug 6; 13 (15):Journal ArticleAcute Declines in Estimated Glomerular Filtration Rate in Patients Treated With Benazepril and Hydrochlorothiazide Versus Amlodipine and Risk of Cardiovascular Outcomes
DOI:10.1161/JAHA.124.035177 PMID: 39056339 -
Olsen E, Soraas CL, Schmieder RE, Jamerson K, Macdonald T, Mancia G, Heimark S, Mehlum MH, Mariampillai J, Liestol K, Larstorp AC, Hoieggen A, Kjeldsen SE, Rostrup M, Mo R, Julius S, Weber MA. Journal of Hypertension, 2024 May 23; 42 (Suppl 1): e114Proceeding / Abstract / PosterACHIEVED SYSTOLIC BLOOD PRESSURE BELOW 130 MMHG PRESERVES KIDNEY FUNCTION IN DIABETIC AND NON-DIABETIC HYPERTENSIVE PATIENTS WITHOUT CARDIAC HYPERTROPHY
DOI:10.1097/01.hjh.0001020452.94022.11 -
Olsen E, Soraas C, Schmieder R, Jamerson K, Macdonald T, Mancia G, Heimark S, Mehlum MH, Mariampullai J, Liestol K, Larstorp AC, Hoieggen A, Kjeldsen SE, Rostrup M, Mo R, Julius S, Weber MA. Journal of Hypertension, 2024 May 23; 42 (Suppl 1): e12 - e13.Proceeding / Abstract / PosterACHIEVED SYSTOLIC BLOOD PRESSURE BELOW 130 MMHG PRESERVES KIDNEY FUNCTION IN HIGH-RISK HYPERTENSIVE PATIENTS WITHOUT CARDIAC HYPERTROPHY BUT WITH PROTEINURIA
DOI:10.1097/01.hjh.0001019436.18284.79 -
Kaciroti N, Jamerson KA, Brook RD. Hypertension, 2024 Mar 1; 81 (3): E13 - E15.Journal ArticleCardiovascular Protection beyond Blood Pressure-Lowering Redux: The ACCOMPLISH trial
DOI:10.1161/HYPERTENSIONAHA.123.22425 PMID: 38354269 -
Flack JM, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Adler SG, Fried L, Jamerson K, Toto R, Brinker M, Farjat AE, Kolkhof P, Lawatscheck R, Joseph A, Bakris GL. Kidney Medicine, 2023 Dec 1; 5 (12):Journal ArticleFinerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials
DOI:10.1016/j.xkme.2023.100730 -
Brook RD, Brook AJ, Jamerson K, Levy PD, Kaciroti N. Journal of the American Heart Association, 2024 Dec 27; 12 (14):Journal ArticleWorse Blood Pressure Levels and Control During Nonsummer Months in Rigorously Treated Patients With Hypertension: The ACCOMPLISH Trial
DOI:10.1161/JAHA.123.030696